Frank, S K <br/><br/>
Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1989 
 - 213-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00451644  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines<br/>Anthraquinones--analysis<br/>Antibiotics, Antineoplastic--analysis<br/>Antineoplastic Agents--analysis<br/>Chromatography, High Pressure Liquid--methods<br/>DNA Damage<br/>DNA, Neoplasm--drug effects<br/>Dogs<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Pyrazoles--analysis<br/>Rats<br/>Rats, Inbred Strains<br/>Rhabdomyosarcoma--metabolism<br/>Tumor Cells, Cultured